Utility of Non-High-Density Lipoprotein Cholesterol Versus Other Lipoprotein Measures in Detecting Subclinical Atherosclerosis in Young Adults (The Bogalusa Heart Study)

American Journal of Cardiology

Volumn 100, Issue 1, 2007, Pages 64-68

  Frontini, Maria G ^a   Srinivasan, Sathanur R ^a   Xu, Ji Hua ^a   Tang, Rong ^b   Bond, M Gene ^b   Berenson, Gerald ^a  

^a Tulane Center for Cardiovascular Health   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; ANALYTIC METHOD; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SYSTOLIC BLOOD PRESSURE;

ADULT; AFRICAN AMERICANS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID ARTERIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIPIDS; LOUISIANA; MALE; RISK FACTORS; TRIGLYCERIDES; TUNICA MEDIA;

EID: 34250714459     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.01.071     Document Type: Article

References (30)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult treatment Panel III). JAMA 285 (2001) 2486-2497
2. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
3. Lamarche B., Moorjani S., Lupien P.J., Cantin B., Bernard P.M., Dagenais G.R., and Despres J.P. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec Cardiovascular Study. Circulation 94 (1996) 273-278
4. Sniderman A.D., Furberg C.D., Keech A., Roeters van Lennep J.E., Frohlich J., Jungner I., and Walldius G. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 361 (2003) 777-780
5. Kwiterovich Jr. P.O., Coresh J., Smith H.H., Bachonle P.S., Derby C.A., and Pearson T.A. Comparison of the plasma level of apolipoproteins B and A-I, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol 69 (1992) 1015-1021
6. Stampfer M.J., Sacks F.M., Salvini S., Willett W.C., and Henneckens C.H. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 325 (1991) 373-381
7. 100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294 (2005) 326-333
8. Xydakis A.M., and Ballantyne C.M. Role of non-high-density lipoprotein cholesterol in prevention of cardiovascular disease: updated evidence from clinical trials. Curr Opin Cardiol 18 (2003) 503-509
9. Cui Y., Blumenthal R.S., Flaws J.A., Whiteman M.K., Langenberg P., Bachorik P.S., and Bush T.L. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161 (2001) 1413-1419
10. Bittner V., Hardison R., Kelsey S.F., Weiner B.H., Jacobs A.K., and Superko G. Non-high-density lipoprotein cholesterol levels predict five year outcome in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 106 (2002) 2537-2542
11. Greenland P., Abrams J., Aurigemma G.P., Bond M.G., Clark L.T., Criqui M.H., Crouse J.R., Friedman L., Fuster V., Herrington D.M., et al. Prevention Conference V: beyond secondary prevention identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 101 suppl (2000) E16-E22
12. Chambless L.E., Heiss G., Folsom A.R., Rosamond W., Szklo M., Sharrett A.R., and Clegg L.X. Association of coronary heart disease incidence with carotid arterial wall thickess and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 146 (1997) 483-494
13. O'Leary D., Polak J., Kronmal R., Manolio T., Burke G., and Wolfson Jr. S. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study. N Engl J Med 340 (1999) 14-22
14. Hodis H.N., Mack W.J., LaBree L., Selzer R.H., Liu C.H., and Azen S.P. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 128 (1998) 262-269
15. The Bogalusa Heart Study 20th Anniversary Symposium. Am J Med Sci 310 suppl 1 (1995) S1-S138
16. Croft J.B., Foster T.A., Parker F.C., Cresanta J.L., Hunter S.M., Webber L.S., Srinivasan S.R., and Berenson G.S. Transitions of cardiovascular risk from adolescence to young adulthood. The Bogalusa Heart Study: IEffects of alterations in lifestyle. J Chron Dis 39 (1986) 81-90
17. Srinivasan S.R., and Berenson G.S. Serum lipoprotein in children and methods for study. In: Lewis L.A. (Ed). CRC Handbook of Electrophoresis: Volume III, Lipoprotein Methodology and Human Studies (1983), CRC Press, Boca Raton, FL 185-204
18. Laurell C.B. Electroimmunoassay. Scand J Clin Lab Invest 29 suppl 124 (1972) 21-37
19. Srinivasan S.R., Freedman D.S., Sharma C., Webber L.S., and Berenson G.S. Serum apolipoproteins A-I and B in 2,854 children from a biracial community: Bogalusa Heart Study. Pediatrics 78 (1986) 189-200
20. Urbina E.M., Srinivasan S.R., Tang R., Bond G., Kieltyka L., and Berenson G.S. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (the Bogalusa Heart Study). Am J Cardiol 90 (2002) 953-958
21. Bond M.G., Barnes R.W., Wiley W.A., Wilmoth S.K., Chambless L.E., Howard G., Owens B., and The ARIC Study group. High-resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) cohort. J Neuroimaging 1 (1991) 168-172
22. Riley W.A., Barnes R.W., Evans G.W., and Burke G.L. Ultrasonic measurement of the elastic modulus of the common carotid artery. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 23 (1992) 1062-1068
23. Rifkind B.M., and Segal P. Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemia. JAMA 250 (1983) 1869-1872
24. Rainwater D.L., McMahan A., Malcom G.T., Scheer W.D., Roheim P.S., McGill Jr. H.C., and Strong J.P. Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. Arterioscler Thromb Vasc Biol 199 (1999) 753-761
25. Frost P.H., and Havel R.J. Rationale for use of non-high-density lipoprotein cholesterol screening and assessment of risk and therapy. Am J Cardiol 81 suppl (1998) 26B-31B
26. Friedewald W., Levy R., and Frederickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, with the use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
27. Gardner C.D., Winkleby M.A., and Fortmann S.P. Population frequency distribution of non-high-density lipoprotein cholesterol (Third national Health and Nutrition Examination Survey [NHANES III]. 1988-1994). Am J Cardiol 86 (2000) 299-304
28. Gardner C.D., Fortmann S.P., and Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276 (1996) 875-881
29. Freedman D.S., Otvos J.D., Jeyarajah E.J., Barboriak J.J., Anderson A.J., and Walker J.A. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 188 (1998) 1046-1053
30. Genest Jr. J.J., Bard J.M., Fruchart J.C., Ordovas J.M., Wilson P.F., and Schaefer E.J. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease. Atherosclerosis 90 (1991) 149-157